Professional Documents
Culture Documents
Infections
Pediatric Critical Care Medicine
Emory University
Childrens Healthcare of Atlanta
ASEPTIC MENINGITIS
Viral, atypical bacteria, fungal, TB
Bartonella henslae
Bordetella pertussis
Borrelia burgdorferi
Brucella spp.
Chlamydia spp.
Ehrlichia, Leptospria spp.
Mycobacteria spp.
Mycoplasma spp.
Rickettsia spp.
Treponema pallidum
Toxoplasma gondii
Entamoeba histolytica
Acanthamoeba
Trichinella
Naegleria
TB Meningitis
Most serious complication of TB infection
Fatal without effective treatment, significant
morbidity even with treatment
In children CNS involvement occurs during
primary infection (rather than reactivation)
Usually results from hematogenous spread from a
primary focus (lungs)
Variable presentation, but usually onset is
insidious
More rapid in infants and young children
TB Meningitis
Clinical Staging
Stage
Stage 1 (Early)
Days to weeks
Stage 2 (intermediate)
Weeks to months
Meningeal irritation
Minor neuro deficits (CN)
Stage 3 (late)
Months to years
Abnormal movements
Convulsions
Stupor or coma
Severe neuro deficits
Diagnosis
* Isolation or identification of mycobacterium is the
gold standard for diagnosis
Possible in about 80% of cases
PCR, ADA, ELISA have varying degrees of accuracy
Treatment
Typically requires at least 3 or 4 drug therapy
Isoniazid, rifampin, pyrazinamide +/- ethambutol or
streptomycin
ENCEPHALITIS AND
MYELITIS
Encephalitis
* Refers to inflammation of the brain parenchyma
* Pathology shows:
Inflammation and destruction of neurons
Pathogen detection by direct visualization, staining, etc
Etiology
* In neonates, the most common etiology is HSV
(usually type 2), but also entero- and adenovirus
* In older children arthropod-borne viruses
(arboviruses) and enteroviruses are the most
common
Arbo: EEE, WEE, St. Louis, West Nile, JE
Entero: polio, echo, coxsackie, etc
Pathogenesis
* Once a virus crosses the epithelium (usually at a
mucosal surface) viral replication occurs, followed
by viremia
* Viruses can penetrate the CSF from the blood, or
by spread from peripheral neurons (rabies and HSV)
* Once in the CNS the virus attaches to host cells
Viral genome replication takes over, affecting the other
functions of the cell
Clinical Manifestations
* Varies depending on affected site, severity, and
host factors
May or may not involve meninges (rabies)
Diagnosis
* CSF findings are non-specific
Cells and protein may be normal or slightly elevated
May see predominance of lymphs
Neuroimaging
Etiology
Site of involvement on
MRI
HSV
Inferomedial temporal
and frontal lobes
Japanese encephalitis
Rabies
Hippocampal, cerebellar,
mesencephalic areas
Eastern equine
encephalitis
Management
* Children with suspected encephalitis warrant ICU
monitoring
* Antimicrobial therapy is appropriate until bacterial
meningitis has been ruled out
* Antiviral therapy should be started when appropriate:
HSV acyclovir
CMV ganciclovir or foscarnet
Flu A/B amantadine/rimantadine (A only), oseltamivir (A and
B)
No specific therapy for entero- and arboviruses
Consider IVIG in immune compromised patients
HSV Encephalitis
HSV is the most common cause of fatal
encephalitis in childhood
Mostly HSV-1 after neonatal period
Older children
Diagnosis
* Swabs from
conjunctiva,
nasopharynx, rectum,
skin lesions
* MRI may show
temporal or frontal
involvement
* PLEDs on EEG
* HSV PCR is 95 %
sensitive and 100%
specific (gold standard)
* Please dont do a brain
biopsy
ADEM
Acute Disseminated Encephalomyelitis
ADEM: Introduction
ADEM is an inflammatory demyelinating disorder
of the CNS
Mostly seen in children and young adults
Can be multiphasic (must distinguish from MS)
Often preceeded by respiratory or GI viral illness
Has also been reported after immunizations
MMR and rabies vaccines
ADEM: Clinical
Presentation
* Mean age of presentation is 7 years, slightly >
males
* Fever, HA rapidly progresses to AMS and
multifocal neuro deficits
Evolution may occur over a few days
ADEM: Diagnosis
The Brighton collaboration has published a very
complicated clinical definition of ADEM
Based on varying levels of diagnostic certainty
histopathology, imaging, presentation, etc
Neuroimaging
ADEM: Treatment
Mainstay of treatment is methylprednisolone 2030 mg/kg/day for 3-5 days
Taper over 3-6 weeks
ADEM: Prognosis
Most children with mild to moderate illness and
appropriate treatment achieve good recovery
Acute mortality is rare
Fulminant cases are at higher risk of mortality
Abscesses: Etiologies
* Most common pathogens include anaerobes,
GNs, streptococci, and staph
* Neonates most commonly get GNs: Citrobacter,
Enterobacter, Proteus
* In other populations the organism depends on
predisposing factors:
CHD a-hemolytic strep
Endocarditis strep, S. aureus
Post-trauma staph
Otitis/sinusitis strep, Bacteroides fragilis, Proteus spp.,
pseudomonas, H.flu
Abscesses: Pathogenesis
* May occur via hematogenous or direct spread
* Cyanotic heart disease is the most common
underlying condition (esp. TOF)
Polycythemia higher viscosity microinfarcts
Bacteria love it!
Abscesses: Pathogenesis
* Bugs localize at the gray-white junction
cerebritis
* Stage 1: Early cerebritis (Day 1-3)
Leukocyte infiltration, focal edema, no clear demarcation
Abscesses: Pathogenesis
Entire process may take 4-6 weeks
May progress faster or rupture into ventricular
system
Sites of infection vary but cerebral are most
common
Kids with CHD get them in MCA distribution
Otitis can spread to unilateral temporal lobe or
cerebellum
Abscesses: Diagnosis
LP would be contraindicated in a patient with
brain or spinal cord abscess
ButCSF may show pleocytosis, protein, normal glc
Abscesses: Imaging
Abscesses: Imaging
Abscesses: Treatment
Surgical drainage or excision is required in many
cases
Usually under CT guidance
Abscesses: Prognosis
Mortality is high in several groups:
Newborns, young infants
Children with multiple large abscesses and CHD
Intramedullary abscess of spinal cord (vs. subdural or
epidural spinal abscesses)
Cerebritis Vasculitis
Shunt Infections
2/3 of all shunt infections are caused by staph
spp
Staph epi, aureus, and other coag-negative types have
been frequently isolated in several series
Pathogenesis
* Shunts are foreign bodies and interfere with
natural host defense mechanisms
Chemotaxis and phagocytosis
Clinical Presentation
Fever, headache, vomiting, lethargy, altered
mental status
Check for wounds and look for cellulitis along the
shunt
Infection may spread to the distal end of the
shunt and cause peritonitis
Diagnosis
Isolation of organisms from CSF or equipment
Other CSF studies are variable
Treatment
Antibiotics are a mainstay of treatment
Some propose shunt removal or externalization only if
there is no response to antibiotics
Fungal Pathogen
Prematurity
Candida albicans
Candida, Cryptococcus,
Aspergillus
Corticosteroids
Cryptococcus, Candida
Cytotoxic agents
Aspergillus, Candida
Secondary immunodeficiency
(AIDS)
Cryptococcus, Histoplasma
Zygomycetes
IV drug abuse
Candida, Zygomycetes
Zygomycetes (Mucor)
Candida
Fungal Meningitis
Most common causes are Cryptococcus
neoformans, C. immitis, Candida, and Aspergillus
Fungal meningitis in general has a more insidious
onset than bacterial
Symptoms may develop over days
Always consider it with subacute/chronic presentation
Fungal Meningitis
Rhinocerebral syndrome is a major presentation
of zygomycosis
Rhizopus and Mucor spp
Associated with poorly controlled DM
Orbital pain, nasal discharge, facial edema, proptosis
Diagnosis
* Have a low index of
suspicion in immune
compromised patients
with fever and CNS
signs
* CSF usually has high
protein, low glucose,
and 20-500 WBCs
Cell count may be LOW
(<20) with AIDS or high
dose steroids
Diagnosis
- Cultures are
frequently negative
Candida takes days to
grow, histo/coccidio take
weeks
- Methenamine stain of
an aspirate or biopsy
can help identify
Aspergillus and
Zygomycetes, which
can cause tissue
invasion and necrosis
Treatment
Fungus
Initial
Regimen
Second
Regimen
Other
Consideration
s
Candida
Amphotericin B
+ flucytosine x
2 wks
Cryptococcus
Ampho B +
flucytosine x 2
wks
Coccidio
Ampho x 4wks
Fluconazole or
ampho 4eva
Serial
monitoring of
CSF
Aspergillus
High dose
ampho +
excision
PO vori or
ampho x 1 yr
Excision is key.
Prognosis
Depends on underlying disease process
Why are they immune suppressed?
PARASITIC CNS
INFECTIONS
Neurocysticercosis
and Cerebral Malaria
Neurocysticercosis
- Most common parasitic
CNS infection.
Important cause of
epilepsy in the tropics.
- Endemic in Latin
America, Mexico, India,
sub-Saharan Africa, and
China.
Including developed
countries.
>1000 new cases are
diagnosed in the US each
year.
Neurocysticercosis
Parenchymal
Extraparenchymal
Seizures in 70-90% of
patients
1/3 will have raised ICP
4% have focal neuro
deficits
May have encephalitis
Rare in children
Obstructive
hyrdocephalous or
chronic meningitis
Spinal involvement
Numerous cysts
Diffuse cerebral edema
Poor prognosis
Radicular pain
Cord compression
Transverse myelitis
Ophthalmic involvement
Vision deficits
Neurocysticercosis
Treatment
- Praziquantel and albendazole are both effective
- But albendazole is better tolerated and penetrates CSF
better.
15 mg/kg/day x 28 days
CEREBRAL MALARIA
Last one!
Cerebral Malaria
Clinical syndrome characterized by CNS
dysfunction associated with Plasmodium
falciparum infection
Becoming more common in developed countries
due to increases in international travel and
migration
Pathophysiology is different in children who grew
up in endemic areas vs. those who are nonimmune
Etiology
P. falciparum causes almost all life-threatening
malaria.
Transmitted by anopheline mosquitos
Epidemiology
Endemic in tropical areas
Southeast Asia, Central/South America, Africa
Pathogenesis
- Plasmodial infections stimulate monocyte
release of cytokines (TNF, IL-1, IL-6)
- Pathogenesis of cerebral malaria is not well
understood
Likely multi-factorial mechanisms of neuro dysfunction
May be due to obstruction of microvasculature
Increased CSF lactate production
Clinical Presentation
- Suspect it in any child who has visited (or even
landed in an airport!) an endemic area and develops
CNS symptoms.
- Fever, HA, irritability, altered mental status.
- Seizures are common.
- Retinopathy (including hemorrhages)
- Metabolic acidosis
- Hypoglycemia (associated with poor prognosis)
In non-immune adults it is from hyperinsulinemia
In African children it is impaired gluconeogenesis.
Diagnosis
CSF is usually acellular consider other diagnosis
if there is pleocytosis
Protein and glucose are normal, CSF lactate is up
Associated with GN sepsis
Parasite count ranges from barely detectable to
>20%
May not be detectable at first
Need blood smears q6h x 48hrs to rule out
Treatment
- Children with severe malaria need parenteral therapy:
Cinchona alkaloids (quinine, quinidine)
Artermisinin compounds (not available in N. America)
first 24 hours.
- Watch glucose, fluid balance, renal function, HCT.
- Exchange transfusion may be indicated for parasitemia
>10% or if not responding to therapy.
- Steroids appear to increase bleeding and offer no
benefit.
Prognosis
Mortality in non-immune patients is 15-26%
Many patients die in the first 4 days from renal
failure or pulmonary edema
African children have similar mortality but they
die in the first 24 hours
Often from herniation, severe hypoglycemia, anemia
Prevention
No vaccine is available for malaria.
Prophylaxis is recommended for travelers.
Mefloquine or atovaqone-proguanil.